Holds 2 active US DMFs for cabozantinib, filing since 2024. Its GMP is recognised in 5 markets.
Holds 3 active US DMFs for cabozantinib, filing since 2025. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for cabozantinib, filing since 2025. Its 2024 FDA inspection closed as VAI.
Holds one active US DMF for cabozantinib, filing since 2026.
Registered with SFDA (Saudi Arabia) for cabozantinib.
This page filters the worldwide Cabozantinib manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for cabozantinib and what filings they hold.
Chat with Fred, your AI analyst